ResMed Adopts New Operating Model to Accelerate Long-term Growth
- Justin Leong appointed Chief Product Officer, effective immediately.
- Katrin Pucknat appointed Chief Marketing Officer, effective immediately.
- Mike Fliss appointed Chief Revenue Officer, effective immediately.
- Rob Douglas, President and Chief Operating Officer, to retire January 1, 2024.
SAN DIEGO, Nov. 09, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced a new operating model to accelerate long-term growth. The new operating model introduces dedicated leadership in Product, Revenue, and Marketing to the global executive team. This change aims to increase the velocity of product development and sharpen our customer and brand focus. Ultimately, the goal is to accelerate profitable growth, while driving greater value and improved care throughout the outside hospital care continuum and the patient journey.
“ResMed is the undisputed leader in digital health for respiratory medicine and residential care, and we aspire to make ourselves even more Product-led, Customer-centric, and Brand-enhanced. Today, we are making bold changes to ensure these capabilities are directly represented in our executive leadership team,” said Mick Farrell, ResMed’s CEO. “We will measure the success of our new operating model through increased product velocity, increased vigilance on long-term profitable revenue delivery, and increased brand engagement with stakeholders.”
ResMed’s new Product-led, Customer-centric, and Brand-enhanced operating model includes the following executive leadership team:
- Leaders appointed into new roles:
- Chief Product Officer – Justin Leong (previously president, Asia and Latin America)
- Chief Marketing Officer – Katrin Pucknat (previously president, Germany)
- Chief Revenue Officer – Mike Fliss (previously vice president, North America sales)
- In addition to the above roles, the executive leadership team also includes:
- Chief Commercial Officer, SaaS – Bobby Ghoshal
- Chief Financial Officer – Brett Sandercock
- Chief Legal Officer – Mike Rider
- Chief People Officer – Vered Keisar
- Chief Strategy Officer – Hemanth Reddy
- The extended CEO operations team, reporting directly to the CEO, includes:
- Chief Compliance Officer – Jim Ellis
- Chief Information Security Officer – Todd Friedman
- Chief Investor Relations Officer – Amy Wakeham
- Chief Medical Officer – Carlos Nunez
- Chief Quality & Regulatory Officer – Dawn Haake
- Chief Supply ChainOfficer – Andrew Price
ResMed also announced that Rob Douglas, current president and chief operating officer, plans to retire on January 1, 2024. Rob will immediately transition from his current role to a new role as special advisor to the CEO and remain in a consulting role through December 31, 2024. Additionally, Lucile Blaise, current president sleep and respiratory care, will immediately transition to a new role as senior vice president, strategy & business development, reporting to Hemanth Reddy. Finally, as part of the operating model evolution, the digital health technology product organization will now report to Justin Leong, and Urvashi Tyagi, current chief technology officer, will immediately transition to a role as special advisor to the Chief Product Officer through January 1, 2024. Urvashi will remain in a consulting role through December 31, 2024.
“I would like to thank Rob immensely for his more than two decades of dedication to ResMed, our company, our culture, our team, and our mission,” said Mick Farrell, ResMed’s CEO. “I wish Rob all the best in his retirement from ResMed, as well as the next phase of his life journey. I would also like to thank Lucile for stepping up in leadership roles for a decade-and-a-half for ResMed, and I know she will continue to contribute strongly to the exciting work of further developing and enhancing our respiratory care strategy. Lastly, I’d like to thank Urvashi for leading our technology organization over the past two years, she’s built a strong team that is well-positioned to support our new product organization. I’m more excited than ever about ResMed’s future, the changes we’ve made position us well to accelerate profitable growth for the benefit of all stakeholders.”
At ResMed (NYSE: RMD, ASX: RMD), we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries. To learn more, visit ResMed.com and follow @ResMed.
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Finanskalender for 20247.12.2023 10:29:26 CET | pressemeddelelse
Meddelelse nr. 11 - 2023 til Nasdaq Copenhagen 7. december 2023 Finanskalender for 2024 Bestyrelsen for BRØDRENE A & O JOHANSEN A/S har vedtaget følgende finanskalender for 2024: Frist for aktionærer for fremsættelse af emner på dagsordenen til den ordinære generalforsamling: 6. februar 2024 Årsrapport for 2023: 21. februar 2024 Ordinær generalforsamling: 20. marts 2024 Delårsrapport for 1. kvartal 2024: 24. april 2024 Delårsrapport for 1. halvår 2024: 14. august 2024 Delårsrapport for 1.-3. kvartal 2024: 23. oktober 2024 Yderligere information fås hos: Adm. direktør Niels A. Johansen Finansdirektør/viceadm. direktør Per Toelstang Brødrene A & O Johansen A/S Rørvang 3 2620 Albertslund Tlf.: 70 28 00 00 Med venlig hilsen BRØDRENE A & O JOHANSEN A/S Niels A. Johansen Vedhæftet fil Finanskalender for 2024
Notification of managers and closely related parties’ transactions with A.P. Møller - Mærsk A/S shares in connection with share buy-back program7.12.2023 09:36:29 CET | Press release
In connection with the announced share buy-back program in A.P. Møller - Mærsk A/S, A.P. Møller Holding A/S continuously sells shares pro rata and the market is to be informed accordingly – see the attached file. Attachment APMM Share buy-back APMH sale 06122023
Indberetning af ledende medarbejderes og disses nærtståendes transaktioner med A.P. Møller - Mærsk A/S aktier i forbindelse med aktietilbagekøbsprogram7.12.2023 09:36:29 CET | pressemeddelelse
I forbindelse med det annoncerede aktietilbagekøbsprogram i A.P. Møller - Mærsk A/S sælger A.P. Møller Holding A/S løbende aktier pro rata og markedet informeres følgeligt herom - se vedhæftede fil. Vedhæftet fil APMM Aktietilbagekøbsprogram APMH salg_06122023
Change in the composition of Sydbank’s Group Executive Management7.12.2023 09:15:00 CET | Press release
Company Announcement No 42/2023 Peberlyk 4 6200 Aabenraa, Denmark Tel +45 70 10 78 79 Fax +45 74 37 35 36 Sydbank A/S CVR No DK 12626509, Aabenraa sydbank.dk 7 December 2023 Dear Sirs Change in the composition of Sydbank’s Group Executive Management The position of Deputy Group Chief Executive with responsibility for Credits and Compliance etc. is handed over to a new member of the Group Executive Management from the Bank’s own ranks. Member of the Group Executive Management and Deputy Group Chief Executive Bjarne Larsen resigns from his position in this connection. Sydbank’s current Group Executive Vice President, Credits, Stig Westergaard, is appointed as Deputy Group Chief Executive with responsibility for Credits and Compliance etc. - The Board of Directors has decided to change the composition of the Group Executive Management. We wished to make a change with a new person in the important role as the officer in charge of Credits and Compliance. We find that Sydbank’s current Group
Sydbank ændrer sammensætningen i direktionen7.12.2023 09:15:00 CET | pressemeddelelse
Selskabsmeddelelse nr. 42/2023 Peberlyk 4 DK-6200 Aabenraa Telefon +45 70 10 78 79 Telefax +45 74 37 35 36 Sydbank A/S CVR-nr. DK 12626509, Aabenraa sydbank.dk 7. december 2023 Sydbank ændrer sammensætningen i direktionen Posten som bankdirektør med ansvar for bl.a. kredit og compliance bliver overdraget til nyt direktionsmedlem, der er fundet internt. Direktionsmedlem og bankdirektør Bjarne Larsen fratræder i den forbindelse. Sydbanks nuværende kreditdirektør Stig Westergaard udnævnes til bankdirektør med ansvar for bl.a. kredit og compliance. - Bestyrelsen har besluttet at ændre ved sammensætningen i direktionen. Vi har ønsket at gennemføre et skifte, med en ny person på den vigtige post som kredit og complianceansvarlig. Her har vi fundet, at Sydbanks nuværende kreditdirektør Stig Westergaard er et stærkt valg for området og banken. I bestyrelsen kender vi Stig Westergaard som en kompetent og meget behagelig samarbejdspartner, siger bestyrelsesformand Lars Mikkelgaard-Jensen. Farvel